Panacea Index Logo

Command Palette

Search for a command to run...

Melatonin treatment effects on adolescent students' sleep timing and sleepiness in a placebo-controlled crossover study.

Chronobiology international
November 1, 2012
Berndt Eckerberg et al. (4 authors)
Journal ArticleRandomized Controlled TrialHuman StudyClinical
Study Details

Study Goal

The researchers aimed to determine whether a small afternoon dose of melatonin could advance sleep timing in teenagers with sleep-onset difficulties.

Results Summary

Melatonin significantly advanced sleep-onset times, increased sleep duration, reduced daytime sleepiness, and improved morning alertness compared to placebo. Evening melatonin levels increased and morning levels decreased, indicating a phase advance in circadian rhythm.

Population

21 students aged 14-19 years with sleep-onset difficulties during school weeks.

Effective Dosage

1 mg daily, administered between 16:30 and 18:00.

Duration

5 weeks (with melatonin administered during specific weeks).

Interactions

None mentioned.

Extracted Claims (9)
InterventionDirectionEndpointPopulationDosageImpactClaim #
melatonin (1 mg) capsules
decrease
reported sleep-onset times
students aged 14-19 yrs with sleep-onset difficulties
-
advanced
#1
melatonin (1 mg) capsules
increase
sleep length
students aged 14-19 yrs with sleep-onset difficulties
-
was longer
#2
melatonin (1 mg) capsules
decrease
sleep timing
students aged 14-19 yrs with sleep-onset difficulties
68 min
fell asleep earlier
#3
melatonin (1 mg) capsules
increase
sleep duration
students aged 14-19 yrs with sleep-onset difficulties
62 min
slept longer
#4
melatonin (1 mg) capsules
decrease
morning melatonin values in saliva
students aged 14-19 yrs with sleep-onset difficulties
-
diminished
#5
melatonin (1 mg) capsules
increase
evening melatonin values in saliva
students aged 14-19 yrs with sleep-onset difficulties
-
increased
#6
melatonin (1 mg) capsules
decrease
wake up
students aged 14-19 yrs with sleep-onset difficulties
-
less
#7
melatonin (1 mg) capsules
decrease
school daytime sleepiness
students aged 14-19 yrs with sleep-onset difficulties
-
less
#8
melatonin (1 mg) capsules
increase
evening sleepiness
students aged 14-19 yrs with sleep-onset difficulties
-
increased
#9
Abstract

During the last few decades, the incidence of sleep-onset insomnia, due to delay of circadian phase, has increased substantially among adolescents all over the world. We wanted to investigate whether a small dose of melatonin given daily, administered in the afternoon, could advance the sleep timing in teenagers. Twenty-one students, aged 14-19 yrs, with sleep-onset difficulties during school weeks were recruited. The study was a randomized, double blind, placebo (PL)-controlled crossover trial, lasting 5 wks. During the first 6 d in wks 2 and 4, the students received either PL or melatonin (1 mg) capsules between 16:30 and 18:00 h. During the first 6 d of wk 5, all students received melatonin. Wks 1 and 3 were capsule-free. In the last evening of each week and the following morning, the students produced saliva samples at home for later melatonin analysis. The samples were produced the same time each week, as late as possible in the evening and as early as possible in the morning. Both the student and one parent received automatic mobile text messages 15 min before saliva sampling times and capsule intake at agreed times. Diaries with registration of presumed sleep, subjective sleepiness during the day (Karolinska Sleepiness Scale, KSS) and times for capsule intake and saliva samplings were completed each day. Primary analysis over 5 wks gave significant results for melatonin, sleep and KSS. Post hoc analysis showed that reported sleep-onset times were advanced after melatonin school weeks compared with PL school weeks (p < .005) and that sleep length was longer (p < .05). After the last melatonin school week, the students fell asleep 68 min earlier and slept 62 min longer each night compared with the baseline week. Morning melatonin values in saliva diminished compared with PL (p < .001) and evening values increased (p < .001), indicating a possible sleep phase advance. Compared with PL school weeks, the students reported less wake up (p < .05), less school daytime sleepiness (p < .05) and increased evening sleepiness (p < .005) during melatonin weeks. We conclude that a small dose of melatonin given daily, administered in the afternoon, could advance the sleep timing and make the students more alert during school days even if they continued their often irregular sleep habits during weekends.

Medical Subject Headings (MeSH)
AdolescentCircadian RhythmCross-Over StudiesDouble-Blind MethodDrug ChronotherapyFemaleHumansMaleMelatoninSalivaSleepSleep Initiation and Maintenance DisordersYoung Adult
Study Links
Quality Scores
Safety85
Efficacy90/10
Quality88/10
Citation Metrics
Total Citations34
Citations/Year2.6
Relative Citation Ratio1.27
NIH Percentile59.2%
Research Impact Scores
APT Score0.75
Weight Score1.57
Normalized Score0.88
Related Supplements